Central Nervous System Webinars - Invicro

Solutions
- - - Solutions
      Invicro's quantitative biomarkers, advanced analytics and imaging solutions enhances the discovery and development of life-changing drugs.
Therapeutic Areas
- - - Therapeutic Areas
      Invicro’s medical imaging capabilities, experience, and expertise span several therapeutic areas.
Capabilities
- - - Capabilites
      Invicro serves top pharma and biotech companies from molecular discovery through late-phase clinical trials.
About
- - - About
      Invicro solves drug development problems through the Design, Capture, Analysis and Management of data.
Resources
- - - Resources
      Enjoy complimentary access to market insights and trends, including publications, case studies, informative webinars and more.
Contact
Subscribe
Search for:

Pathology

Utilization of 3D Fluorescent Imaging in Multi-modality Studies

3D Tissue Imaging to Characterize Gene Therapies in Preclinical Drug Discovery

In Vivo and Tissue Molecular Imaging in Gene Therapy

Clinical

The Evolution of RANO Criteria: Improving Accuracy in Brain Tumor Assessment

Neuroimaging and Psychedelics

Roundtable Discussion: The Role of Parkinson’s Disease Biomarkers in Drug Development Clinical Trials

The Future of Imaging Biomarkers in Alzheimer's Disease Clinical Trials

Deep Quantitative Super-resolution for Integrative Studies of Neurodegenerative Disease

Multi-purpose in vivo Imaging in Intracranial Tumor Models to Support Clinical Translation in Neuro-oncology

Understanding the Intricacies of Fluorine-18 and Carbon-11 for Radiolabeling Success

New Outcomes, Old Measures; New Measures, Old Outcomes: Integrative Strategies for Optimizing Biomarkers in Clinical Trials of Neurodegenerative Disease

Imaging Mitochondrial-ER-Synapse Dysfunction in Neurodegeneration – The MIND MAPS Programme

[Roundtable] The Future of Imaging Biomarkers in Alzheimer's Disease Clinical Trials

EXPLORER as a Transformational Imaging Technology for Drug Development

Molecular Imaging in Neurodegenerative Disorders: Developing a Translational Toolbox

Wherefore art Tau? Developing Methods for the Qualitative Interpretation of Tau PET

The IQ Analytics Platform: Amyloid-IQ, Tau-IQ, and Dat-IQ

What Can We Learn From Primary Age-Related Tauopathy (PART)

Applications of Machine Learning in Medical Image Analysis

Advanced Imaging Biomarkers in Alzheimer's Disease

Image Acquisition is Easy; Constructing Data Analysis Workflows that Work for you is the Challenging and Critical Part

Obtaining High Quality Imaging Data from Clinical Trials

What’s New in iPACS and VivoQuant With an Eye on the Future

Translational Aspects of Intrathecal Drug Administration

Machine Learning & Deep Learning for Image Processing Applications

Imaging Biomarkers for Measuring Pharmacodynamic Effects of CNS Drugs

How MRI is Helping to De-risk Drug Development

In Vivo and Tissue Molecular Imaging in Gene Therapy

Molecular & Functional Imaging in Early Phase Drug Development

AmyloidIQ – An algorithm to increase power in clinical trials and automate radiological reads

Preclinical

A novel 3D approach to imaging gene therapy expression and vector biodistribution

Deep Quantitative Super-resolution for Integrative Studies of Neurodegenerative Disease

Multi-purpose in vivo Imaging in Intracranial Tumor Models to Support Clinical Translation in Neuro-oncology

Understanding the Intricacies of Fluorine-18 and Carbon-11 for Radiolabeling Success

From Lumbar Puncture to Brain Parenchyma: Obstacles to Efficient and Repeatable Intrathecal Drug Administration

CNS Probe Development, Validation and Utility in Drug R&D. What Have We Learnt From Small Molecules to Antibodies?

Development of Novel PET Radioligands for PET Imaging Applications

Utilization of 3D Fluorescent Imaging in Multi-modality Studies

What’s New in iPACS and VivoQuant With an Eye on the Future

Image Acquisition is Easy; Constructing Data Analysis Workflows that Work for you is the Challenging and Critical Part

Applications of Machine Learning in Medical Image Analysis

3D Tissue Imaging to Characterize Gene Therapies in Preclinical Drug Discovery

Translational Aspects of Intrathecal Drug Administration

Machine Learning & Deep Learning for Image Processing Applications

How MRI is Helping to De-risk Drug Development

In Vivo and Tissue Molecular Imaging in Gene Therapy

Go Back to all Webinars